Featured Story

Hospital scanning centers: Not just for humans anymore

Last fall, the Johns Hopkins Hospital in Maryland opened a new medical-imaging center that provides the latest advances in MRI scanning and other services. What's unusual about the center, however, is not so much the technology but rather the mix of clientele.

Bayer study reveals growth opportunity for vet clinics in fighting parasites

A survey of 2,000 pet owners conducted by Bayer HealthCare Animal Health and the Companion Animal Parasite Council has revealed that when veterinarians provide information to clients about parasites prevalent in their area, they can drive up clinic visits.

Harvard engineer taps immunotherapy for insights into nonsurgical pet sterilization

Harvard University engineer David Mooney believes there may be a link between immunotherapy and sterilization. He recently received a $700,000 grant to develop a contraceptive vaccine for pets.

Report: Livestock research lab prioritizes profits over animal health

The U.S. Meat Animal Research Center aims to invent livestock that will improve the meat industry's efficiency by producing more offspring at lower costs. But reaching that goal comes at a great cost to the animals' health, according to a heartbreaking story in The New York Times.

PetMed's sales fall but profit margins expand on rising demand for pricier products

PetMed Express announced Tuesday that sales in its third fiscal quarter, ended Dec. 31, fell 1.6% to $49.3 million from the same period a year ago, while net income rose 5.6% to $4.8 million, or 24 cents per share. The Florida-based company, known to consumers as 1-800-PetMeds, declared a quarterly dividend of 17 cents.


From Our Sister Sites


Pfizer got a federal judge to toss an investor lawsuit last year tied its now-withdrawn pain drug Bextra. But it wasn't the only investor suit raising similar issues, namely that the board had not been forthright about issues with the drugs. Another was just days away from trial, that is until the drugmaker agreed to settle it for $400 million.


Investors sent Royal Philips down 5% after it disclosed its 2014 earnings report. Analysts on the call clearly remained unconvinced that the $1.2 billion acquisition of catheter-based imaging company Volcano announced in mid-December would help the company. It's in the midst of making the transition to being solely focused on HealthTech, a combination of healthcare and consumer businesses.